EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Serum Asprosin Concentrations and Severity in Acute Pancreatitis: A Prospective Case–Control Study with Serial Measurements

Mehmet Fatih Uzanulu iD, Musa Ak iD, Levent Bolat iD, Onur Selçuk Yiğit iD, Cihat Uçar iD, Hacı Mehmet Çitil iD, Handan Kanat Seyhan

Diagnostics · 09.11.2026 · 16 (21) · 3700

DOI: 10.3390/diagnostics16213700 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diagnostics, online erschienen am 09.11.2026. Verfasst von Mehmet Fatih Uzanulu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Malatya Turgut Ozal University Training and Research Hospital, 44430 Malatya, Türkiye. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Malatya Turgut Özal Üniversitesi.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Asprosin is a fasting-induced glucogenic adipokine with pro-inflammatory effects in experimental models, but its behaviour in acute pancreatitis (AP) is unknown. In this exploratory study, we examined whether circulating asprosin differs between patients with AP and healthy controls, how it changes during hospitalisation and whether it is associated with disease severity.

Methods

In this prospective case–control study, 82 patients with AP (of 183 screened, after exclusion of diabetes, hypertriglyceridaemia and morbid obesity) and 82 sex-matched healthy controls were enrolled. Serum asprosin was measured by ELISA at admission, 72 h and 120 h in patients and once in fasting controls. Severity was defined by the revised Atlanta classification. Because patients were older and heavier than controls, the group difference was adjusted for age, body mass index and sex and examined in post hoc matched subsamples.

Results

Admission asprosin was 4.52 (2.94–5.89) ng/mL in patients and 3.55 (2.24–4.92) ng/mL in controls (p = 0.071); the ratio of geometric means adjusted for age, body mass index and sex was 1.17 (95% CI 0.85–1.61). Asprosin was higher in patients in post hoc age- and sex-matched pairs (median difference 1.91 ng/mL, 95% CI 0.24–3.78) but not in body mass index- and sex-matched pairs (0.96 ng/mL, −0.34 to 2.72). Asprosin changed little over five days and was not associated with moderately severe or severe AP (AUC 0.57, upper 95% confidence limits ≤0.71); only seven patients had severe AP.

Conclusions

In this exploratory study, serum asprosin was modestly and non-significantly higher in patients with AP than in controls, and no statistically significant association with severity was detected. Residual confounding by age and body mass index, the exclusion of patients with diabetes or hypertriglyceridaemia (≥200 mg/dL) and the absence of in-house assay validation preclude firm conclusions. These data provide effect estimates for adequately powered, matched studies of asprosin in AP.

Schlagwörter

Stichwörter der Autor:innen

acute pancreatitisadipokineasprosinbiomarkerdisease severityrevised Atlanta classification

Autor:innen und Institutionen

  • Department of Internal Medicine, Malatya Turgut Ozal University Training and Research Hospital, 44430 Malatya, Türkiye.
  • Division of Hematology, Department of Internal Medicine, Istanbul Faculty of Medicine, Istanbul University, 34093 Istanbul, Türkiye.
  • Department of General Surgery, Osmaniye Training and Research Hospital, 80010 Osmaniye, Türkiye.
  • Department of Internal Medicine, Ordu State Hospital, 52200 Ordu, Türkiye.
  • Department of Physiology, Faculty of Medicine, Malatya Turgut Ozal University, 44210 Malatya, Türkiye.

ORCID-Profile: Mehmet Fatih Uzanulu, Musa Ak, Levent Bolat, Onur Selçuk Yiğit, Cihat Uçar, Hacı Mehmet Çitil

Förderung

  • Malatya Turgut Özal Üniversitesi

Zitieren

APA

Uzanulu, M. F., Ak, M., Bolat, L., Yiğit, O. S., Uçar, C., Çitil, H. M., & Seyhan, H. K. (2026). Serum Asprosin Concentrations and Severity in Acute Pancreatitis: A Prospective Case–Control Study with Serial Measurements. Diagnostics, 16(21), 3700. https://doi.org/10.3390/diagnostics16213700

Vancouver

Uzanulu MF, Ak M, Bolat L, Yiğit OS, Uçar C, Çitil HM, et al. Serum Asprosin Concentrations and Severity in Acute Pancreatitis: A Prospective Case–Control Study with Serial Measurements. Diagnostics. 2026;16(21):3700. doi:10.3390/diagnostics16213700

BibTeX
@article{Uzanulu2026,
  author = {Uzanulu, Mehmet Fatih and Ak, Musa and Bolat, Levent and Yiğit, Onur Selçuk and Uçar, Cihat and Çitil, Hacı Mehmet and Seyhan, Handan Kanat},
  title = {Serum Asprosin Concentrations and Severity in Acute Pancreatitis: A Prospective Case–Control Study with Serial Measurements},
  journal = {Diagnostics},
  year = {2026},
  volume = {16},
  number = {21},
  pages = {3700},
  doi = {10.3390/diagnostics16213700}
}
Kostenlos starten →